Insys Therapeutics competitorsClear all

Insys Therapeutics's top competitors include Assertio Therapeutics, ImmVira, Telix Pharmaceuticals and ImmunSYS.
Insys Therapeutics
Insys Therapeutics
Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative supportive care products.
Assertio Therapeutics
Assertio Therapeutics
Assertio Therapeutics (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other.
ImmVira
ImmVira
ImmVira is a company that develops biopharmaceutical technology in the field of immunotherapy.
Telix Pharmaceuticals
Telix Pharmaceuticals
Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care.
ImmunSYS
ImmunSYS
ImmunSYS is a biopharmaceutical company developing cancer immunotherapy products.
Founding Date
Founding Date
1998
Founding Date
1995
Founding Date
2015
Founding Date
2017
Founding Date
2018
Type
Type
Public
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Chandler, US HQ
Chandler, US
Round Rock, US
Locations
Newark, US HQ
Lake Forest, US
Locations
Shenzhen Shi, CN HQ
Locations
North Melbourne, AU HQ
Etterbeek, BE
Herstal, BE
Kyoto, JP
Indianapolis, US
Locations
Fort Lauderdale, US HQ
Employees
Employees
22634% decrease
Employees
11632% decrease
Employees
5
Employees
N/A
Employees
1011% increase
Valuation ($)
Valuation ($)
3.1 m
Valuation ($)
70.8 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
498
Twitter followers
65
Alexa Website Rank
Alexa Website Rank
352142
Alexa Website Rank
364635
Alexa Website Rank
480141
Alexa Website Rank
341293
Alexa Website Rank
242243
Employee Rating
Employee Rating
2.1
Employee Rating
3.9
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
$82.1m (FY, 2018)
Revenue (est.)
$229.5m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$10.8m (FY, 2018)
Cost of goods
$9.5m (FY, 2019)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$71.3m (FY, 2018)
Gross profit
$220m (FY, 2019)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($124.5m) (FY, 2018)
Net income
($217.2m) (FY, 2019)
Net income
N/A
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 2.3m
Total funding raised
$ 875m
Total funding raised
$ 90.5m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Assertio Therapeutics
HQ
Newark, US
Employees
116↓ 32% decrease

Assertio Therapeutics (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other.

View company
ImmVira
HQ
Shenzhen Shi, CN
Employees
5

ImmVira is a company that develops biopharmaceutical technology in the field of immunotherapy.

View company
Telix Pharmaceuticals
HQ
North Melbourne, AU

Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care.

View company
ImmunSYS
HQ
Fort Lauderdale, US
Employees
10↑ 11% increase

ImmunSYS is a biopharmaceutical company developing cancer immunotherapy products.

View company